JBM (Healthcare) Limited

SEHK:2161 Stock Report

Market Cap: HK$1.5b

JBM (Healthcare) Future Growth

Future criteria checks 3/6

JBM (Healthcare) is forecast to grow earnings and revenue by 13.2% and 13.9% per annum respectively. EPS is expected to grow by 13.8% per annum. Return on equity is forecast to be 16.8% in 3 years.

Key information

13.2%

Earnings growth rate

13.8%

EPS growth rate

Pharmaceuticals earnings growth12.0%
Revenue growth rate13.9%
Future return on equity16.8%
Analyst coverage

Low

Last updated14 Mar 2025

Recent future growth updates

No updates

Recent updates

JBM (Healthcare) Limited (HKG:2161) Stock Rockets 35% But Many Are Still Ignoring The Company

Nov 08
JBM (Healthcare) Limited (HKG:2161) Stock Rockets 35% But Many Are Still Ignoring The Company

JBM (Healthcare)'s (HKG:2161) Earnings Are Weaker Than They Seem

Dec 20
JBM (Healthcare)'s (HKG:2161) Earnings Are Weaker Than They Seem

Here's Why JBM (Healthcare) (HKG:2161) Has Caught The Eye Of Investors

Nov 01
Here's Why JBM (Healthcare) (HKG:2161) Has Caught The Eye Of Investors

JBM (Healthcare) Limited's (HKG:2161) Shares May Have Run Too Fast Too Soon

Jul 29
JBM (Healthcare) Limited's (HKG:2161) Shares May Have Run Too Fast Too Soon

Some Investors May Be Willing To Look Past JBM (Healthcare)'s (HKG:2161) Soft Earnings

Aug 03
Some Investors May Be Willing To Look Past JBM (Healthcare)'s (HKG:2161) Soft Earnings

Estimating The Fair Value Of JBM (Healthcare) Limited (HKG:2161)

Jul 28
Estimating The Fair Value Of JBM (Healthcare) Limited (HKG:2161)

Earnings and Revenue Growth Forecasts

SEHK:2161 - Analysts future estimates and past financials data (HKD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/20271,017222N/A2461
3/31/2026894193N/A2161
3/31/2025780165N/A1531
9/30/2024721164254261N/A
6/30/2024684147218226N/A
3/31/2024648130181191N/A
12/31/2023629114156168N/A
9/30/202361098130144N/A
6/30/202356578134145N/A
3/31/202352057137146N/A
12/31/202248747122129N/A
9/30/202245436106113N/A
6/30/2022430307987N/A
3/31/2022406255360N/A
12/31/2021398183038N/A
9/30/202139011816N/A
6/30/2021394172237N/A
3/31/2021397233659N/A
3/31/2020382413438N/A
3/31/2019308524857N/A
3/31/201826442N/A82N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 2161's forecast earnings growth (13.2% per year) is above the savings rate (2.4%).

Earnings vs Market: 2161's earnings (13.2% per year) are forecast to grow faster than the Hong Kong market (11.5% per year).

High Growth Earnings: 2161's earnings are forecast to grow, but not significantly.

Revenue vs Market: 2161's revenue (13.9% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).

High Growth Revenue: 2161's revenue (13.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 2161's Return on Equity is forecast to be low in 3 years time (16.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/19 21:07
End of Day Share Price 2025/03/19 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

JBM (Healthcare) Limited is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xiao Qin DouUOB Kay Hian Research Pte Ltd
Kate LuangUOB Kay Hian Research Pte Ltd
Gigi CheukUOB Kay Hian Research Pte Ltd